News Item: Company Touts $599 Whole Genome, Suspends Operations, Needing Cash

The highest-rated article today on Genomeweb is an open-access article about Veritas Genetics suspending operations.  See the article here.

• Veritas, a Harvard Med School spinout, raised $30M in 2016, and a total of $42M.
• Per Genomeweb, it offered whole genome for $999, BRCA for $199, 26-gene panel for $299.
• Recently offered whole genome for $599.
• Suspended operations "due to adverse financing" when "planned financing fell through."